The list below is a sampling of the many open BMT clinical trials for ALL at University of Minnesota Medical Center. Click on the highlighted links below for a printable pdf summary of selected studies. We will be adding new summaries in the future, so please be sure to visit us again. For information on additional trials, please call 612-273-2800.

CR1 (High Risk); CR2 or greater

Allo Transplant for Heme Malignancy (MT2001-02)

Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)
     Patient summary: Myeloablative Umbilical Cord Transplant (2005-10) 

Reduced Intensity Allo Bone Marrow Transplant (MT2001-10)

Reduced Intensity UCB Transplant (MT2005-02)
     Patient Summary: Reduced Intensity Umbilical Cord Transplantation (2005-02)

Bu/Cy/Mel Allo Transplant for Heme Malignancy (MT 2000-12)

Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT2008-38)

Treg in Sibling Allo Transplant (MT2004-03)

UCB Tregs after Reduced Intensity Transplant (MT 2006-01)

CTN: Siro/Tac vs. Mtx/Tac for GVHD Prophylaxis (MT-2006-18)

Reduced Intensity UCB Transplant with C3a Priming (MT-2008-15)

Relapsed or Refractory

Chemo DLI (MT2003-15)

Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)
 
Decitabine and Vorinostat + Chemo for Relapsed/Refractory ALL (MT2008-29)